MIG CAPITAL AG

MIG Capital portfolio company Inbolt raises €15 million in Series A to further develop AI-powered 3D vision in robots

MIG Capital co-leads €63 million Series A round for autoimmune biotech SciRhom

MIG Capital invests in GlassPoint to accelerate innovation in decarbonized industrial heat through solar thermal power

MIG Capital leads €5 million Series A financing of animal healthcare company HawkCell to democratise MRI imaging

MIG Capital announces stable development in fiscal year 2023, optimistic outlook for 2024

MIG Capital co-leads seed investment in French space tech company Look Up Space

MIG Capital strengthens its investment team with four new professionals

MIG Capital participates in €54 million Series C extension round for AMSilk

MIG Capital leads €15 million financing round for talpasolutions with Robert Bosch Venture Capital

MIG Capital leads €13 million Series A financing of microbiome therapeutics biotech mbiomics

MIG Capital fosters solid development in European deep tech and life science sectors in 2022

MIG Capital participates in €130 million financing round for plastic recycling specialist APK

MIG Capital supports €128 million funding of quantum computer company IQM

MIG Capital continues to grow after excellent financial year 2021

MIG Capital leads seed financing for French start-up Inbolt

MIG Capital leads €22.5 million Series B financing for Mimi Hearing Technologies

MIG Fonds leads €65 million Series B financing of iOmx Therapeutics

MIG sells portfolio company Hemovent to MicroPort

MIG portfolio company AMSilk completes €29 million financing round

MIG AG records 2020 as the most successful year in its company history and aims at further growth

Creative Balloons closes €15 million growth financing and appoints Frank Gehres as CEO

Germany’s MIG Fonds makes first French investment with deep-tech company Zadient Technologies

MIG funds increases BioNTech dividend payments to a record €600 million

European innovation reaches EU population: MIG Fonds’ portfolio company BioNTech achieves positive CHMP opinion for the first COVID-19 and mRNA vaccine

MIG Fonds invests in German Bionic Systems

MIG Fonds’ portfolio company BioNTech receives first COVID-19 vaccine approval – private risk capital was crucial

MIG Funds: Successful sale of shares in B.R.A.I.N. AG

MIG Verwaltungs AG: MIG Funds sell shares in B.R.A.I.N. AG